Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease.
@article{Pagani1996ExpressionOL, title={Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease.}, author={Franco Pagani and R Garc{\'i}a and R Pariyarath and Cristiana Stuani and B. Gridelli and Gianni Paone and Francisco E. Baralle}, journal={Human molecular genetics}, year={1996}, volume={5 10}, pages={ 1611-7 } }
Lysosomal acid lipase (LAL) gene mutations were identified in three patients with cholesteryl ester storage disease (CESD). Direct sequencing of genomic DNA revealed that: patient 1 was a compound heterozygote for a P181L mutation and an A to G3' splice site substitution that causes skipping of exon 7, with a loss of 49 amino acids from LAL (delta 205-253); patient 2 was a compound heterozygote for a G66V mutation and a 5' splice site mutation (G to A) that leads to skipping of exon 8 (delta…
48 Citations
Cholesteryl ester storage disease: relationship between molecular defects and in situ activity of lysosomal acid lipase.
- BiologyBiochemical and molecular medicine
- 1997
There is no simple direct correlation between the LAL molecular lesions and the biochemical and clinical phenotypes, according to researchers studying the catabolic turnover of radiolabeled cholesteryl oleate in intact cells.
New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.
- BiologyJournal of lipid research
- 1998
Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.
- BiologyMolecular genetics and metabolism
- 1998
The results suggest that E8SJM leads to essentially a null allele and that the differences in WD and CESD phenotype involve other factors.
A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease.
- BiologyClinica chimica acta; international journal of clinical chemistry
- 2008
Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
- BiologyMolecular genetics and metabolism
- 1999
Although it is not easily demonstrated in conventional assays, CESD is distinct from WD in that at least one mutant allele has the potential to produce enough residual enzymatic function to ameliorate the phenotype; in the majority of CESD cases this may come from a single, easily detected, splicing mutation in one allele.
Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease.
- BiologyJournal of lipid research
- 2000
Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency.
- Medicine, BiologyAnnals of hepatology
- 2019
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations.
- Medicine, BiologyNutrition, metabolism, and cardiovascular diseases : NMCD
- 2013
Crystal structure of human lysosomal acid lipase and its implications in cholesteryl ester storage disease[S]
- BiologyJournal of Lipid Research
- 2020
The first crystal structure of recombinant human LAL (HLAL) is presented to 2.6 Å resolution in its closed form and a possible role of the human mutant, H274Y, leading to CESD is speculated.
Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.
- BiologyHuman molecular genetics
- 1998
The lal-/lal- mice provide a model to determine the role of LAL in lipid metabolism and the pathogenesis of its deficiency states and are a phenotypic model of human CESD, and a biochemical and histopathologic mimic of human WD.
References
SHOWING 1-10 OF 31 REFERENCES
Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.
- BiologyProceedings of the National Academy of Sciences of the United States of America
- 1994
Two mutations are each capable of completely disrupting the catalytic function of the lysosomal acid cholesteryl ester hydrolase and their presence can account for the extreme phenotype of the LYSosomal lipid storage disorder manifested in members of this patient's family.
A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease.
- BiologyJournal of lipid research
- 1995
To establish the molecular defects in LAL deficiency, two unrelated probands with severely reduced LAL activity were examined and DNA amplification by reverse-transcription polymerase chain reaction and subsequent sequence analysis of LAL cDNA identified two mutant alleles.
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
- BiologyGenomics
- 1996
The combined data provide evidence that the only functionally relevant genetic difference between the Wolman patients and the CESD patient is that the splice defect in Wolman does not permit any correct splicing, whereas the defect observed in CESD allows some correctsplicing (3% of total LAL mRNA) and therefore the synthesis of functional enzyme.
A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.
- Biology, MedicineThe Journal of clinical investigation
- 1993
Evidence is presented that deletion of the codons for amino acids 254-277 in the LAL mRNA in combination with a null allele cause the clinical expression of CESD in a 12-yr-old patient.
Characterization of Lysosomal Acid Lipase by Site-directed Mutagenesis and Heterologous Expression (*)
- Biology, ChemistryThe Journal of Biological Chemistry
- 1995
Mechanisms, in addition to LAL defects, may operate in the selective accumulation of cholesterol esters or triglycerides in CESD and WD patients.
[Acid lipase deficiency (Wolman disease and cholesteryl ester storage disease: CESD)].
- Biology, MedicineRyoikibetsu shokogun shirizu
- 1998
It is suggested that structural gene defects are also present in CESD cells, however, the reason (s) for the clinical difference between Wolman disease and CESD remain (S) to be studied.
[Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].
- Biology, MedicineNihon rinsho. Japanese journal of clinical medicine
- 1995
It is suggested that structural gene defects are also present in CESD cells, however, the reason (s) for the clinical difference between Wolman disease and CESD remain (S) to be studied.
Genomic organization of the human lysosomal acid lipase gene (LIPA).
- BiologyGenomics
- 1994
A summary of the exon structure of the entire human lysosomal acid lipase gene consisting of 10 exons, together with the sizes of genomic EcoRI and SacI fragments hybridizing to each exon is presented.
Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases.
- Biology, ChemistryThe Journal of biological chemistry
- 1991
Genetic variation of human mononuclear leukocyte lysosomal acid lipase activity. Relationship to atherosclerosis.
- Biology, MedicineAtherosclerosis
- 1986